SyntheX

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://synthexlabs.com/

Last Round

Series A

Jan 11, 2024

Est. Valuation

$3.13M

Total Funding Raised

$18.05M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

SyntheX is a biotechnology company that utilizes genetically engineered circuits and proprietary DNA-encoded libraries to discover novel therapeutics for cancer and rare diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

synthetic biologydrug discoverytargeted protein degradationprotein-protein interactionmolecular gluecell-based selectionundruggable targetsbiotech platformTPDPPIoncology therapeuticsrare disease researchdrug discovery partnerbiopharma collaborationfunctional genomics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SyntheX Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SyntheX Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jan 11, 2024
Debt	Apr 27, 2020
Seed	Apr 27, 2017
Seed	Feb 14, 2017
Accelerator	Jul 15, 2016
Accelerator	Mar 1, 2016

View all Funding Rounds

Key People

Founding team and executive leadership

Maria Soloveychik

Co-founder, CEO

Founding Team

SyntheX Investors

Notable investors and investment history

Investor	Rounds
Morgan Noble Healthcare Partners	Series A
IndieBio	Seed, Accelerator
Oriza Ventures	Seed, Series A
OMX Ventures	Seed, Series A
8VC	Seed, Series A
SOSV	Accelerator, Seed, Series A
SVB Financial Group	Debt

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jun 28, 2026
Grew 18% QoQ, from 34 to 40 employees.

View all signals

SyntheX Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SyntheX Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SyntheX's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Employee Range40

Year Founded2016

Last FundingJan 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.